BIOMAT Database Logo BIOMAT Database Logo

Quasi morphine-abstinence syndrome. 1974

H O Collier, and D L Francis, and G Henderson, and C Schneider

UI MeSH Term Description Entries
D008297 Male Males
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009021 Morphine Dependence Strong dependence, both physiological and emotional, upon morphine. Morphine Abuse,Morphine Addiction,Abuse, Morphine,Addiction, Morphine,Dependence, Morphine
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D003932 Heroin A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Diacetylmorphine,Diamorphine,Diacetylmorphine Hydrochloride,Diagesil,Diamorf,Heroin Hydrochloride,Min-I-Jet Morphine Sulphate,Hydrochloride, Diacetylmorphine,Hydrochloride, Heroin,Min I Jet Morphine Sulphate
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H O Collier, and D L Francis, and G Henderson, and C Schneider
Nociceptin/orphanin FQ (N/OFQ) induces a quasi-morphine abstinence syndrome in the rat.
September 2000, Psychopharmacology,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Incidence of morphine withdrawal and quasi-abstinence syndrome in a model of chronic pain in the rat.
October 1987, Neuroscience letters,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Morphine versus clonidine for neonatal abstinence syndrome.
February 2015, Pediatrics,
H O Collier, and D L Francis, and G Henderson, and C Schneider
[EFFECTS OF CENTROPHENOXINE ON THE MORPHINE ABSTINENCE SYNDROME].
January 1964, Therapie,
H O Collier, and D L Francis, and G Henderson, and C Schneider
[Studies concerning amelioration of the morphine abstinence syndrome ].
January 1978, Revista de medicina interna, neurologie, psihiatrie, neurochirurgie, dermato-venerologie. Neurologie, psihiatrie, neurochirurgie,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Analog of neuropeptide FF attenuates morphine abstinence syndrome.
January 1991, Peptides,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Quasi-morphine withdrawal syndrome: recent developments. Introduction.
April 1981, Federation proceedings,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Nalorphine-induced abstinence syndrome in morphine-tolerant albino rats.
May 1956, The Journal of pharmacology and experimental therapeutics,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Administration of pellets of morphine to mice; abstinence syndrome.
January 1961, Acta physiologica latino americana,
H O Collier, and D L Francis, and G Henderson, and C Schneider
Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome.
October 1982, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!